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Introduction
Histamine plays a pivotal role in a number of processes,
including inflammation, allergic reaction, gastric acid secre-
tion and neurotransmission. These actions are mediated by
the activation of specific histamine receptors, namely H1, H2,
H3 and H4. Histamine levels in cells and in tissues are regu-
lated by the activity of histidine decarboxylase (HDC), that is
the only enzyme responsible for the generation of histamine
from L-histidine [1]. Therefore, HDC can serve as a specific
marker for the biosynthesis of histamine. It has been hypoth-
esized that histamine could regulate tumor cell growth; in
fact the activation of H2 receptors leads to cell proliferation
through the transcription of the protooncogene c-fos. Hista-
mine stimulates the in vitro and in vivo growth of gastroin-
testinal cancer cells and treatment with cimetidine, an H2
antagonist, can reverse this effect [2]. Tumor invasion and
metastases are clinically more relevant than tumor growth
and histamine has been reported to act as an angiogenic fac-
tor, inducing vascular endothelial growth factor production
in granulation tissue [3]. Moreover, histamine seems to be
also involved in inhibition of the local immune response
against cancer.
In the present study, we determined histamine content
and HDC activity in human colorectal cancer and correlated
them with tumor stages and intratumor microvessel density
(MVD).
Materials and methods
Patients and tissue collection
Tissue samples were obtained from 27 patients (13 males, 14 females;
median age 64 years) who had consecutively undergone surgical resec-
tions for colorectal adenocarcinomas at the General Surgery Unit, Uni-
versity of Florence, Italy. All the patients were informed about the aims
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of the study and gave written consent for the investigation. Cancers were
classified into four stages according to the American Joint Commette on
Cancer staging system. Tissue samples from the edge of the tumor and
normal mucosa 10 cm far from the tumor were excised from each
patient. The samples were either washed in PBS and frozen at –80°C for
use in the HDC and histamine assay or fixed in 4% formaldehyde and
embedded in paraffin for immunostaining.
Biochemical determinations, immunostaining 
and microvessel counting
Histidine decarboxylase activity was assayed by measuring 14CO2
evolved from L-[carboxyl 14C]-histidine (46 mCi/mmol, Amersham,
England) using a previously reported method [4]. Histamine content
was determined after a buthanol/heptane extraction from the tissue,
using a fluorometric method as previously reported [5]. Sections were
cut from the formaldehyde-fixed and paraffin-embedded tissue blocks
and processed as previously described [6]. Immunohistochemical stain-
ing was performed using the streptavidin-biotin peroxidase method.
Staining for CD31, an endothelial antigen, was used to highlight the
endothelial cells and determine MVD [5].
Statistical analysis
MVD values, HDC activity and histamine content were expressed as
means ± SEM. The relationship between MVD, HDC activity and hist-
amine content was evaluated using the Spearman correlation cefficient
(rs). P values less than 0.05 were considered statistically significant.
Results and discussion
HDC and histamine content were significantly higher in the
tumor specimens than in the corresponding normal mucosa
(42.3 ± 2.2 vs 14.8 ± 1.3 nmol histamine/mg protein/h, p <
0.001 and 26.3 ± 2.6 vs 0.6 ± 0.3 ng/mg protein, p < 0.001,
respectively). These parameters were also significantly high-
er in tumors with lymph node and/or hematogenous metas-
tases (stages III–IV) than in those without any metastases
(stages I–II; Table 1). Histamine content was higher in tu-
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mors with a higher immunostaining for MVD, although HDC
activity did not correlate with MVD. When all the patients
were considered, the mean value of MVD was 26.5 ± 2.3
microvessels per field.
The hypothesis that histamine could be involved in car-
cinogenesis and tumor proliferation was proposed in the
1960s, but the question is poorly defined until now and in
these latter years, accumulated evidence has pointed to the
direct relationship between HDC activity and tumor growth.
Our results demonstrated that both HDC activity and hista-
mine content were significantly higher in tumor specimens
than in the corresponding normal mucosa, and showed for
the first time that high level of HDC activity and histamine
content correlated with the presence of lymph and/or distant
metastases (rs = 0.42, p < 0.01 and rs = 0.30, p < 0.05 respec-
tively). These data strongly suggest a role of histamine in the
acquisition of an invasive and metastatic phenotype for col-
orectal cancer cells. The specific mechanism by which HDC
and histamine are involved in cancer progression is poorly
understood. Histamine has been reported to be a potent
angiogenic factor in some inflammatory models, but our
results seem not to support the hypothesis of a direct involve-
ment of histamine in inducing tumor angiogenesis, in fact
intratumoral HDC activity and histamine content did not cor-
relate with MVD. Histamine has been reported to have an
immunosuppressive effect and our findings also support the
hypothesis that the histamine high content of tumors could
represent one of the underlying causes of local decreased
immune response against colonic cancer.
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Normal mucosa Tumor stage I–II Tumor stage III–IV
H content 0.6 ± 0.3 21.4 ± 1.8* 35.2 ± 3.1**
(ng/mg protein)
HDC activity 14.8 ± 1.0 34.6 ± 2.9* 50.45 ± 3.6**
(nmoles H/mg protein per h)
*p < 0.001 vs normal mucosa; **p < 0.001 vs normal mucosa and tumor stage I–II.
Table 1. Histamine (H) content and
histidine decarboxylase (HDC) activity
in tumor samples and in normal mucosa
(taken 10 cm from the tumor) from
colonic cancer patients.
